A detailed history of State Board Of Administration Of Florida Retirement System transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, State Board Of Administration Of Florida Retirement System holds 34,168 shares of DNLI stock, worth $734,270. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,168
Previous 34,168 -0.0%
Holding current value
$734,270
Previous $793,000 25.47%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$14.96 - $23.22 $28,124 - $43,653
1,880 Added 5.82%
34,168 $793,000
Q1 2024

May 08, 2024

SELL
$15.83 - $23.35 $22,636 - $33,390
-1,430 Reduced 4.24%
32,288 $662,000
Q3 2023

Nov 08, 2023

BUY
$20.63 - $30.17 $3,713 - $5,430
180 Added 0.54%
33,718 $695,000
Q2 2023

Aug 11, 2023

BUY
$23.37 - $32.96 $29,212 - $41,200
1,250 Added 3.87%
33,538 $989,000
Q2 2022

Aug 05, 2022

BUY
$20.88 - $35.19 $38,001 - $64,045
1,820 Added 5.97%
32,288 $950,000
Q4 2021

Feb 08, 2022

BUY
$42.59 - $55.02 $19,122 - $24,703
449 Added 1.5%
30,468 $1.36 Million
Q3 2021

Nov 08, 2021

BUY
$48.48 - $78.23 $29,087 - $46,938
600 Added 2.04%
30,019 $1.51 Million
Q2 2021

Aug 10, 2021

BUY
$50.3 - $78.44 $281,881 - $439,577
5,604 Added 23.53%
29,419 $2.31 Million
Q1 2021

May 10, 2021

SELL
$53.8 - $81.53 $26,900 - $40,765
-500 Reduced 2.06%
23,815 $1.36 Million
Q4 2020

Feb 08, 2021

BUY
$36.89 - $93.56 $105,505 - $267,581
2,860 Added 13.33%
24,315 $2.04 Million
Q3 2020

Nov 09, 2020

BUY
$23.13 - $38.84 $20,817 - $34,956
900 Added 4.38%
21,455 $769,000
Q2 2019

Aug 05, 2019

BUY
$18.5 - $28.14 $61,605 - $93,706
3,330 Added 19.33%
20,555 $427,000
Q1 2019

May 03, 2019

BUY
$17.99 - $24.65 $5,217 - $7,148
290 Added 1.71%
17,225 $400,000
Q4 2018

Feb 01, 2019

BUY
$13.88 - $21.75 $235,057 - $368,336
16,935 New
16,935 $350,000

Others Institutions Holding DNLI

About Denali Therapeutics Inc.


  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $2.88B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.